Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study
Floris C. Loeff, Teresa Tsakok, Lisanne Dijk, M. Hart, Michael Duckworth, David Baudry, Alice Russell, Nick Dand, Astrid van Leeuwen, Christopher Em Griffiths, Nick J. Reynolds, Juliet N. Barker, A. David Burden, Richard B. Warren, Annick de Vries, Karien Bloem, Gertjan Wolbink, Catherine Smith, Theo Rispens, Juliet N. Barker, Marilyn Benham, A. David Burden, Ian M. Evans, Christopher Em Griffiths, Sagair Hussain, Brian Kirby, Linda Lawson, K.J. Mason, Kathleen McElhone, Ruth Murphy, Anthony D. Ormerod, Caroline Owen, Nick J. Reynolds, Catherine Smith, Richard B. Warren, Juliet N. Barker, Michael R. Barnes, A. David Burden, Paola DiMeglio, Richard Emsley, Andrea Evans, Christopher Em Griffiths, Katherine Payne, Nick J. Reynolds, Catherine Smith, Deborah Stocken, Richard B. Warren (2020). Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study. , 140(11), DOI: https://doi.org/10.1016/j.jid.2020.03.957.
